Ma. Fatima Francisco Procter & Gamble CO (PG) insider trading activity

Ma. Fatima Francisco is CEO - Baby, Fem & Family Care of PROCTER & GAMBLE Co. Currently has a direct ownership of 13,727 shares of PG, which is worth approximately $2.32 Million. The most recent transaction as insider was on Dec 15, 2020, when has been sold 33 shares (Common Stock) at a price of $136.85 per share, resulting in proceeds of $4,516. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.7K

0.04% 3M change

23.37% 12M change

Total Value Held $2.32 Million

Ma. Fatima Francisco Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 15 2020	SELL Payment of exercise price or tax liability	$4,516 $136.85 p/Share	33 Reduced 0.18%	17,830 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	$4,516 $136.85 p/Share	33 Added 0.18%	17,863 Common Stock
Aug 18 2020	SELL Open market or private sale	$1,451,177 $136.53 p/Share	10,629 Reduced 37.36%	17,825 Common Stock
Aug 18 2020	BUY Grant, award, or other acquisition	-	27,582 Added 49.22%	28,454 Common Stock
Feb 21 2020	SELL Open market or private sale	$383,250 $127.75 p/Share	3,000 Reduced 77.7%	861 Common Stock
Jan 24 2020	SELL Open market or private sale	$379,500 $126.5 p/Share	3,000 Reduced 43.76%	3,856 Common Stock
Nov 26 2019	SELL Open market or private sale	$210,938 $122.0 p/Share	1,729 Reduced 20.14%	6,856 Common Stock
Nov 20 2019	SELL Payment of exercise price or tax liability	$3,049 $121.95 p/Share	25 Reduced 0.29%	8,585 Common Stock
Nov 20 2019	BUY Exercise of conversion of derivative security	$3,049 $121.95 p/Share	25 Added 0.29%	8,610 Common Stock
Aug 26 2019	SELL Open market or private sale	$547,162 $119.0 p/Share	4,598 Reduced 34.89%	8,579 Common Stock
Aug 20 2019	SELL Open market or private sale	$836,563 $119.8 p/Share	6,983 Reduced 34.64%	13,177 Common Stock
Aug 20 2019	BUY Grant, award, or other acquisition	-	14,710 Added 42.19%	20,160 Common Stock
May 16 2019	SELL Open market or private sale	$1,498,000 $107.0 p/Share	14,000 Reduced 72.01%	5,442 Common Stock
May 16 2019	BUY Exercise of conversion of derivative security	$1,101,240 $78.66 p/Share	14,000 Added 41.86%	19,442 Common Stock
May 10 2019	SELL Open market or private sale	$1,496,412 $105.5 p/Share	14,184 Reduced 72.29%	5,436 Common Stock
May 10 2019	BUY Exercise of conversion of derivative security	$1,115,713 $78.66 p/Share	14,184 Added 41.96%	19,620 Common Stock
Feb 13 2019	SELL Open market or private sale	$895,500 $99.5 p/Share	9,000 Reduced 62.37%	5,430 Common Stock
Feb 13 2019	BUY Exercise of conversion of derivative security	$685,620 $76.18 p/Share	9,000 Added 38.41%	14,430 Common Stock
Feb 12 2019	SELL Open market or private sale	$891,000 $99.0 p/Share	9,000 Reduced 62.37%	5,430 Common Stock
Feb 12 2019	BUY Exercise of conversion of derivative security	$685,620 $76.18 p/Share	9,000 Added 38.41%	14,430 Common Stock
Feb 06 2019	SELL Open market or private sale	$921,686 $98.01 p/Share	9,404 Reduced 63.39%	5,430 Common Stock
Feb 06 2019	BUY Exercise of conversion of derivative security	$716,397 $76.18 p/Share	9,404 Added 38.8%	14,834 Common Stock
Aug 22 2018	SELL Open market or private sale	$183,577 $83.52 p/Share	2,198 Reduced 28.84%	5,424 Common Stock
Aug 22 2018	BUY Grant, award, or other acquisition	-	6,796 Added 47.14%	7,622 Common Stock
Aug 06 2018	SELL Payment of exercise price or tax liability	$3,908 $81.41 p/Share	48 Reduced 5.54%	819 Common Stock

Also insider at

HPQ

HP INC Technology

OGN

Organon & Co. Healthcare

Director

MFF